Dundas Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-180,191
| Closed | -$10.7M | – | 56 |
|
|
2021
Q3 | $10.7M | Hold |
180,191
| – | – | 1.5% | 33 |
|
|
2021
Q2 | $12M | Buy |
180,191
+9,696
| +6% | +$648K | 1.75% | 33 |
|
|
2021
Q1 | $10.8M | Hold |
170,495
| – | – | 1.71% | 33 |
|
|
2020
Q4 | $12.1M | Buy |
170,495
+13,293
| +8% | +$942K | 1.77% | 31 |
|
|
2020
Q3 | $9.48M | Hold |
157,202
| – | – | 1.9% | 29 |
|
|
2020
Q2 | $9.24M | Hold |
157,202
| – | – | 2.02% | 29 |
|
|
2020
Q1 | $8.78M | Buy |
157,202
+6,249
| +4% | +$349K | 2.3% | 24 |
|
|
2019
Q4 | $9.68M | Buy |
150,953
+3,660
| +2% | +$235K | 2.19% | 26 |
|
|
2019
Q3 | $7.47M | Hold |
147,293
| – | – | 1.86% | 27 |
|
|
2019
Q2 | $6.68M | Buy |
147,293
+2,864
| +2% | +$130K | 1.56% | 30 |
|
|
2019
Q1 | $6.85M | Hold |
144,429
| – | – | 1.69% | 29 |
|
|
2018
Q4 | $10M | Hold |
144,429
| – | – | 2.18% | 26 |
|
|
2018
Q3 | $11.6M | Buy |
144,429
+38,987
| +37% | +$3.14M | 2.35% | 27 |
|
|
2018
Q2 | $5.85M | Sell |
105,442
-20,265
| -16% | -$1.12M | 1.99% | 27 |
|
|
2018
Q1 | $7.58M | Buy |
+125,707
| New | +$7.58M | 2.35% | 24 |
|